RPAM

Rhenman & Partners Asset Management Portfolio holdings

AUM $791M
1-Year Est. Return 12.81%
This Quarter Est. Return
1 Year Est. Return
+12.81%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$791M
AUM Growth
-$79M
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
105
New
Increased
Reduced
Closed

Top Buys

1 +$15.7M
2 +$12.6M
3 +$12.1M
4
CAH icon
Cardinal Health
CAH
+$9.24M
5
NBIX icon
Neurocrine Biosciences
NBIX
+$7.47M

Top Sells

1 +$19.8M
2 +$15.2M
3 +$14.9M
4
UNH icon
UnitedHealth
UNH
+$14.7M
5
MCK icon
McKesson
MCK
+$14.3M

Sector Composition

1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
UHS icon
51
Universal Health Services
UHS
$13.6B
$4.71M 0.6%
+26,000
SYK icon
52
Stryker
SYK
$147B
$4.55M 0.58%
+11,500
TMO icon
53
Thermo Fisher Scientific
TMO
$213B
$4.52M 0.57%
11,140
-1,500
ACLX icon
54
Arcellx
ACLX
$4.81B
$4.43M 0.56%
67,250
+23,750
EW icon
55
Edwards Lifesciences
EW
$47.4B
$4.3M 0.54%
+55,000
TGTX icon
56
TG Therapeutics
TGTX
$5.35B
$4.14M 0.52%
115,000
-62,500
NUVL icon
57
Nuvalent
NUVL
$7.05B
$4.01M 0.51%
52,500
INSP icon
58
Inspire Medical Systems
INSP
$2.31B
$3.96M 0.5%
30,500
+14,500
BNTX icon
59
BioNTech
BNTX
$25.5B
$3.82M 0.48%
35,870
+120
CYTK icon
60
Cytokinetics
CYTK
$7.2B
$3.44M 0.44%
104,250
RARE icon
61
Ultragenyx Pharmaceutical
RARE
$3.4B
$3.39M 0.43%
93,100
+11,100
MIRM icon
62
Mirum Pharmaceuticals
MIRM
$3.6B
$3.35M 0.42%
65,755
-8,000
GPCR icon
63
Structure Therapeutics
GPCR
$1.65B
$2.8M 0.35%
135,100
+65,100
RDNT icon
64
RadNet
RDNT
$6.29B
$2.62M 0.33%
+46,000
VCEL icon
65
Vericel Corp
VCEL
$1.84B
$2.47M 0.31%
+58,000
RGEN icon
66
Repligen
RGEN
$9.06B
$2.43M 0.31%
19,500
+15,000
LIVN icon
67
LivaNova
LIVN
$2.96B
$2.39M 0.3%
+53,000
DNTH icon
68
Dianthus Therapeutics
DNTH
$1.33B
$2.36M 0.3%
126,627
VKTX icon
69
Viking Therapeutics
VKTX
$4.06B
$2.25M 0.28%
85,000
-15,000
MLTX icon
70
MoonLake Immunotherapeutics
MLTX
$639M
$2.12M 0.27%
45,000
NRIX icon
71
Nurix Therapeutics
NRIX
$1.21B
$2.11M 0.27%
185,000
-64,336
PRVA icon
72
Privia Health
PRVA
$3.16B
$2.1M 0.27%
91,189
-7,000
IQV icon
73
IQVIA
IQV
$37B
$2.05M 0.26%
13,000
-9,000
KRYS icon
74
Krystal Biotech
KRYS
$5.5B
$1.75M 0.22%
12,750
-5,000
SMMT icon
75
Summit Therapeutics
SMMT
$14.5B
$1.66M 0.21%
+78,000